Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J.V. McMurray, Anna-Maria Langkilde, Tzvetana Katova et al.|New England Journal of Medicine|2019Cited by 6.8k
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Javed Butler et al.|New England Journal of Medicine|2021Cited by 4.6k
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D. Solomon, Subodh Verma, John J.V. McMurray et al.|New England Journal of Medicine|2024Cited by 693
The continuous heart failure spectrum: moving beyond an ejection fraction classificationFilippos Triposkiadis, Gilles W. De Keulenaer, Javed Butler et al.|European Heart Journal|2019Cited by 258
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of HypertensionStefan D. Anker, Giuseppe Rosano, Muhammad Usman et al.|European Journal of Heart Failure|2023Cited by 187